rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2008-6-13
|
pubmed:abstractText |
Pheochromocytomas are malignant in approximately 10% of patients. The histologic differentiation between benign and malignant tumors is difficult, the latter diagnosed by the presence of metastatic disease or recurrence.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1532-7361
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
143
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
759-68
|
pubmed:meshHeading |
pubmed-meshheading:18549892-Adolescent,
pubmed-meshheading:18549892-Adrenal Gland Neoplasms,
pubmed-meshheading:18549892-Adult,
pubmed-meshheading:18549892-Aged,
pubmed-meshheading:18549892-Apoptosis,
pubmed-meshheading:18549892-Cell Cycle,
pubmed-meshheading:18549892-Diagnosis, Differential,
pubmed-meshheading:18549892-Female,
pubmed-meshheading:18549892-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18549892-Humans,
pubmed-meshheading:18549892-Ki-67 Antigen,
pubmed-meshheading:18549892-Male,
pubmed-meshheading:18549892-Middle Aged,
pubmed-meshheading:18549892-Necrosis,
pubmed-meshheading:18549892-Neoplasm Recurrence, Local,
pubmed-meshheading:18549892-Pheochromocytoma,
pubmed-meshheading:18549892-Predictive Value of Tests,
pubmed-meshheading:18549892-Prognosis,
pubmed-meshheading:18549892-Prospective Studies,
pubmed-meshheading:18549892-Risk Factors,
pubmed-meshheading:18549892-Severity of Illness Index,
pubmed-meshheading:18549892-Single-Blind Method,
pubmed-meshheading:18549892-Tumor Markers, Biological
|
pubmed:year |
2008
|
pubmed:articleTitle |
Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
|
pubmed:affiliation |
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|